Z-0614-2013 Class II Terminated

Recalled by Roche Molecular Systems, Inc. — Branchburg, NJ

FDA device recall Z-0614-2013 was initiated by Roche Molecular Systems, Inc. on Oct 11, 2012 and is designated Class II. Reason for recall: Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged… The recall status is terminated (terminated Sep 11, 2013). Affected quantity: 7 units.

Recall details

Product Type
Devices
Report Date
Jan 2, 2013
Initiation Date
Oct 11, 2012
Termination Date
Sep 11, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7 units

Product description

COBAS AmpliPrep Instrument (CAP) with AMPLILINK (AL) Software v.3.3.5 Automated sample processing instrument used with CAP/CA and CAP/CTM. Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA Made in Switzerland

Reason for recall

Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.

Distribution pattern

Distributed in the states of GA, CA, NC, and MN.

Code information

CAP 394436 to 394663

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0614-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0614-2013. Report a data issue: hello@regdatalab.com.